Effects of lacosamide, a novel sodium channel modulator, on dorsal horn neuronal responses in a rat model of neuropathy

Neuropharmacology

Volumn 57, Issue 4, 2009, Pages 472-479

  Bee, Lucy Ann ^a   Dickenson, Anthony H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Lacosamide; Neuropathy; Pain; Sodium channels; Spinal cord

Indexed keywords

HARKOSERIDE; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ELECTROPHYSIOLOGY; EVOKED CORTICAL RESPONSE; HYPERSENSITIVITY; IN VIVO STUDY; MALE; NERVE CELL; NERVE LIGATION; NERVE POTENTIAL; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SHAM PROCEDURE; SPRAGUE DAWLEY RAT;

ACETAMIDES; ACTION POTENTIALS; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS; LUMBAR VERTEBRAE; MALE; MICROELECTRODES; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNEL BLOCKERS; SPINAL NERVES; TIME FACTORS;

EID: 68749094130     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.021     Document Type: Article

References (39)

1. Besse D., Lombard M.C., and Besson J.M. Autoradiographic distribution of mu, delta and kappa opioid binding sites in the superficial dorsal horn, over the rostrocaudal axis of the rat spinal cord. Brain Res. 548 (1991) 287-291
2. Beyreuther B., Callizot N., and Stöhr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res. Ther. 9 (2007) R14
3. Beyreuther B.K., Callizot N., Brot M.D., Feldman R., Bain S.C., and Stöhr T. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur. J. Pharmacol. 565 (2007) 98-104
4. Beyreuther B.K., Freitag J., Heers C., Krebsfänger N., Scharfenecker U., and Stöhr T. Lacosamide: a review of preclinical properties. CNS Drug Rev. 13 (2007) 21-42
5. Beyreuther B.K., Geis C., Stohr T., and Sommer C. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology 52 (2007) 1312-1317
6. + current slow inactivation in adaptation of action potential firing in small-diameter dorsal root ganglion neurons. J. Neurosci. 23 (2003) 10338-10350
7. Boucher T.J., and McMahon S.B. Neurotrophic factors and neuropathic pain. Curr. Opin. Pharmacol. 1 (2001) 66-72
8. Courtney K.R., and Etter E.F. Modulated anticonvulsant block of sodium channels in nerve and muscle. Eur. J. Pharmacol. 88 (1983) 1-9
9. Errington A.C., Coyne L., Stohr T., Selve N., and Lees G. Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 50 (2006) 1016-1029
10. Errington A.C., Stöhr T., Heers C., and Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol. Pharmacol. 73 (2008) 157-169
11. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., and Woodruff G.N. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 271 (1996) 5768-5776
12. v1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. 23 (2003) 8881-8892
13. Hansson P. Neuropathic pain: clinical characteristics and diagnostic workup. Eur. J. Pain 6 Suppl. A (2002) 47-50
14. Hansson P.T., and Dickenson A.H. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 113 (2005) 251-254
15. Hao J.X., Stöhr T., Selve N., Wiesenfeld-Hallin Z., and Xu X.J. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur. J. Pharmacol. 553 (2006) 135-140
16. Jensen T.S., Gottrup H., Sindrup S.H., and Bach F.W. The clinical picture of neuropathic pain. Eur. J. Pharmacol. 429 (2001) 1-11
17. Kim C.H., Oh Y., Chung J.M., and Chung K. The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res. Mol. Brain Res. 95 (2001) 153-161
18. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
19. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73 (1997) 123-139
20. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C.I., and Myers R.R. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Ther. 303 (2002) 1199-1205
21. McMahon S.B., and Jones N.G. Plasticity of pain signaling: role of neurotrophic factors exemplified by acid-induced pain. J. Neurobiol. 61 (2004) 72-87
22. McQuay H., Carroll D., Jadad A.R., Wiffen P., and Moore A. Anticonvulsant drugs for management of pain: a systematic review. Br. Med. J. 311 (1995) 1047-1052
23. Neumcke B., Fox J.M., Drouin H., and Schwarz W. Kinetics of the slow variation of peak sodium current in the membrane of myelinated nerve following changes of holding potential or extracellular pH. Biochim. Biophys. Acta 426 (1976) 245-257
24. Ochoa J.L., Campero M., Serra J., and Bostock H. Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy. Muscle Nerve 32 (2005) 459-472
25. Okuse K., Chaplan S.R., McMahon S.B., Luo Z.D., Calcutt N.A., Scott B.P., Akopian A.N., and Wood J.N. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain. Mol. Cell. Neurosci. 10 (1997) 196-207
26. Pezet S., and McMahon S.B. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. (2006)
27. Pinto V., Szucs P., Derkach V.A., and Safronov B.V. Monosynaptic convergence of C- and Adelta-afferent fibres from different segmental dorsal roots on to single substantia gelatinosa neurones in the rat spinal cord. J. Physiol. 586 (2008) 4165-4177
28. Ruben P.C., Starkus J.G., and Rayner M.D. Steady-state availability of sodium channels. Interactions between activation and slow inactivation. Biophys. J. 61 (1992) 941-955
29. Sheets P.L., Heers C., Stöhr T., and Cummins T.R. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J. Pharmacol. Exp. Ther. 326 (2008) 89-99
30. Stöhr T., Krause E., and Selve N. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur. J. Pain 10 (2006) 241-249
31. Sun Q., Tu H., Xing G.G., Han J.S., and Wan Y. Ectopic discharges from injured nerve fibers are highly correlated with tactile allodynia only in early, but not late, stage in rats with spinal nerve ligation. Exp. Neurol. 191 (2005) 128-136
32. Suzuki R., and Dickenson A.H. Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp. Neurol. 198 (2006) 72-80
33. Suzuki R., Kontinen V.K., Matthews E., Williams E., and Dickenson A.H. Enlargement of the receptive field size to low intensity mechanical stimulation in the rat spinal nerve ligation model of neuropathy. Exp. Neurol. 163 (2000) 408-413
34. Tabo E., Jinks S.L., Eisele Jr. J.H., and Carstens E. Behavioral manifestations of neuropathic pain and mechanical allodynia, and changes in spinal dorsal horn neurons, following L4-L6 dorsal root constriction in rats. Pain 80 (1999) 503-520
35. + channels. J. Neurosci. 18 (1998) 1893-1903
36. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., and Serra J. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology (2007)
37. Ulbricht W. Sodium channel inactivation: molecular determinants and modulation. Physiol. Rev. 85 (2005) 1271-1301
38. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769
39. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A., and Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120 (2005) 137-149